Vaccitech PLC reports results for the quarter ended in June - Earnings Summary

Barinthus Biotherapeutics

12/08/2021 14:59

* Vaccitech PLC  VACC.OQ  reported a quarterly adjusted loss
of 64 cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 74 cents per share.
* Revenue was $35.00 thousand​;  analysts expected $100.00
thousand. 
* Vaccitech PLC's reported EPS for the quarter was a loss of 64
cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Vaccitech PLC shares had fallen by 12.0% this quarter.
* The company reported a quarterly loss of $15.93 million.
* Wall Street's median 12-month price target for Vaccitech PLC
is $24.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 12 at 01:59 p.m.  ​All
figures in US dollars unless otherwise stated